The stock has experienced significant volatility and a pronounced downtrend over the past six months. From a peak near $414 in late November 2025, the price has fallen sharply to a current level of $297.8, representing a 6-month decline of 7.5%. Short-term performance has been particularly weak, with the stock down 21.6% over the last three months and 6.8% over the past month, significantly underperforming the broader market as indicated by negative relative strength figures. The current price of $297.8 sits near the lower end of its 52-week range of $275.05 to $414.15, approximately 28% below the high. This positioning suggests the stock is in a corrective phase, having given back most of its gains from late 2025. The price action shows a clear breakdown from the $380-$400 support zone in February 2026, leading to the current lower trading range. No specific technical indicators like RSI were provided in the key metrics for the current date. The data shows a beta of 1.2, indicating the stock has been more volatile than the market, which aligns with the observed price swings. The recent price change of +1.51% from the previous close offers a minor reprieve within the broader downtrend.

Revenue and profitability show mixed signals. Quarterly revenue for Q4 2025 was $932.4 million, representing a year-over-year growth of 6.8%. However, net income for the same quarter was $225.2 million, resulting in a net margin of 24.2%, which is a decline from the 26.5% net margin in Q4 2024. The trailing twelve-month free cash flow is a healthy $539.8 million. Financial health appears stable. The debt-to-equity ratio is 0.55, indicating a moderate level of debt financing. The company generates substantial operating cash flow, as evidenced by the quarterly figures, which supports its ability to service debt and invest in operations. The current ratio data is inconsistent in the provided inputs, with key metrics showing 0, while historical ratios show figures above 1.5, suggesting potential data discrepancies. Operational efficiency metrics are strong. Return on Equity (ROE) is 25.1% and Return on Assets (ROA) is 11.5%, both indicating effective use of shareholder capital and company assets. The gross margin remains robust at 57.8%, and the operating margin is 28.2%, reflecting solid core business profitability.